Driving your fibrosis drug discovery goals to success. Choose the right tissue analysis approach to answer your questions.

Precise characterization of therapeutic effects within intact tissue architecture is essential for understanding mechanistic activity in fibrotic disease.

Our Spatial Biology group employs multiplex immunofluorescence, RNA spatial profiling, and high resolution histological imaging to quantify collagen deposition, fibroblast activation states, immune–stromal interactions, and regional heterogeneity within fibrotic lesions.

These spatially resolved datasets allow us to track how candidate therapeutics modulate microenvironmental niches, providing a robust framework for mechanistic interpretation and translational prediction beyond conventional in vitro or bulk tissue assays.

Download the infographic to learn how to drive your fibrosis drug discovery program forward.